Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2004-06-30
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. In the eyes found to have macular haemorrhages secondary to choroidal neovascularisation, we hope to identify the risk factors for the development of choroidal neovascularisation in high myopia
3. To study the functional outcome of these eyes as assessed by visual acuity
4. To study the morphological outcome of these eyes by clinical assessment (and fundal photography) and fluorescein angiography
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To identify the underlying aetiologies of macular haemorrhages in myopic eyes
* To study the functional and morphological outcome of these eyes with macular haemorrhages 6 months later Secondary Aims
* To study the subgroup of eyes with myopic choroidal neovascularisation (CNV), in particular the risk factors for CNV in myopes
* To study the subgroup of eyes with macular haemorrhages in the absence of CNV
Plan of investigation:
1. Patient with myopia (\>-6.00DS) presents with loss of central vision
2. Examination reveals a macular haemorrhage
3. Investigations
* Refraction
* Axial length\*
* Fundus fluorescein angiography
* Indocyanine green angiography\*
4. Determine if a myopic CNV is present or absent
5. Management of patient: Treatment vs No treatment
* Treatment being
1. Conventional laser
2. PDT
6. Review at 6 months
* BCVA
* Clinical appearance (fundal photo)
* FFA
7. Review at 12 months
* BCVA
* Clinical appearance
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Macular haemorrhage
Exclusion Criteria
* Allergy to fluorescein or indocyanine green dyes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore National Eye Centre
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shu-Yen Lee, FRCSEd
Role: PRINCIPAL_INVESTIGATOR
Singapore National Eye Centre
Chong-Lye Ang, FRCOphth
Role: STUDY_CHAIR
Singapore National Eye Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore National Eye Centre
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R347/05/2004
Identifier Type: -
Identifier Source: org_study_id